ABSTRACT
As PDE5 inhibitors are in effect vasodilators, they may have an important therapeutic role when vasoconstriction is clinically important. Research progresses in hypertension, cardiac failure and Raynaud’s phenomenon.32,33
The therapeutic potential is exciting, given the reports of major benefits in treating pulmonary hypertension.34
